Aetiology
Inflammatory carcinoma of the breast (ICB) is a rare and aggressive type of breast cancer. It is believed that inflammatory carcinoma of the breast is caused by an abnormal immune response to cancer cells in the breast, which triggers inflammation and an overgrowth of cancer cells.
Diagnosis
ICB is usually diagnosed by mammography, ultrasound, and MRI. The diagnosis is confirmed through biopsy.
Differential diagnosis
Differential diagnosis of ICB includes other inflammatory breast diseases such as mastitis, lymphoma, and inflammatory skin disorders.
Treatment
ICB is usually treated with chemotherapy, radiation therapy, and surgery. In some cases, targeted therapies such as immunotherapy and hormone therapy may also be used.
Prognosis
The prognosis for ICB is generally poor, as it is a highly aggressive form of breast cancer. Treatment may help to slow the progression of the disease, but it is often not curable.